Skip to main
MLYS
MLYS logo

MLYS Market Capitalization Overview

Market Cap: $2.96B as of Oct 3, 2025

$2.96B
Past Month+$645.23M (27.97%)
As of Oct 3, 2025, MLYS has a market capitalization of $2.96B. Over the past 30 days, its market cap has increased by 61.4%, while in the last 12 months, it has increased by 381.89%.

Market capitalization represents the total value of Mineralys Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

MLYS Market Cap Formula = Stock Price * Shares Outstanding

The market cap of MLYS helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

MLYS Market Cap History

DateMarket CapChange
Oct 1, 2025$3.09B+61.40%
Sep 2, 2025$1.92B+114.83%
Aug 1, 2025$890.63M-0.26%
Jul 1, 2025$892.91M-12.74%
Jun 2, 2025$1.03B+5.43%
May 1, 2025$970.55M+11.69%
Apr 1, 2025$868.95M+95.04%
Mar 3, 2025$445.54M-9.85%
Feb 3, 2025$494.21M-18.94%
Jan 2, 2025$609.67M-9.19%

MLYS End of Year Market Cap History

DateMarket CapChange
2025$2.96B+381.89%
2024$612.66M+73.31%
2023$353.51M

FAQs About Mineralys Therapeutics Inc (MLYS) Market Cap

As of Oct 3, 2025, the market capitalization of MLYS is $2.96B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Mineralys Therapeutics Inc’s market capitalization has increased by 27.97%, changing from $2.31B to $2.96B as of Oct 3, 2025.

In the last 3 months, Mineralys Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Mineralys Therapeutics Inc’s market capitalization increased from $353.51M in January to $612.66M in December, reflecting a 73.31% change.

In the past five years, MLYS has had a compound annual growth rate (CAGR) of 31.65% in market capitalization. This means its market cap has grown at an average rate of 31.65% per year.

Mineralys Therapeutics Inc (MLYS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.